PHORM INTERIORS LTD
Company number 12446035 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
PHORM INTERIORS LTD - Analysis Report
Company Number: 12446035
Analysis Date: 2025-07-29 13:47 UTC
Financial Health Assessment for PHORM INTERIORS LTD
1. Financial Health Score: Grade F
Explanation:
The company is classified as dormant with minimal financial activity and no operational transactions recorded in the latest financial year. Net assets and shareholders’ funds remain static at £100, indicating no business growth or financial movement. This static position reflects a "financial coma" state, where the company is essentially inactive with no vital financial signs of trading or revenue generation.
2. Key Vital Signs
| Metric | Value | Interpretation |
|---|---|---|
| Company Status | Active | Legally active but dormant operationally |
| Account Category | Dormant | No significant financial transactions during the year |
| Net Assets | £100 | Minimal asset base, no growth or retained earnings |
| Share Capital | £100 | Small capital injection, typical for start-up phase |
| Cash (last reported) | £100 | Very low cash reserves, no operational cash flow |
| Directors | 2 current | Governance in place, but no operational activity noted |
| Significant Control | 75-100% shares | Single controlling shareholder, concentrated ownership |
3. Diagnosis
The company exhibits classic "symptoms of dormancy," with no operational trading or financial activity since incorporation in 2020. The balance sheet remains flat with net assets and shareholders’ funds constant at £100, reflecting no business growth or cash generation. This lack of transactional data signals that the company has not engaged in trading or business operations during the reported periods.
Being dormant means the company is not generating revenue or incurring expenses, akin to a patient in a medically induced coma. The company is legally registered and maintains compliance with filing deadlines, which is a positive sign for maintaining structural health but does not reflect active business vitality.
No signs of financial distress or liabilities are evident due to inactivity, but equally, there are no signs of financial health or growth. The limited cash and asset position indicate no operational runway to initiate or expand business activities without new capital or strategic interventions.
4. Recommendations
Activate Business Operations or Formal Closure: If the company intends to trade, it must move beyond dormancy by initiating business activities, generating revenue, and maintaining proper accounting records. Otherwise, consider formal liquidation or striking off to reduce administrative burden and costs.
Capital Injection: To transition from dormancy, infusion of working capital is essential to fund operational expenses, marketing, and growth initiatives. The current capital base of £100 is insufficient for meaningful business activity.
Strategic Review: Conduct a business plan review to assess market opportunities and define clear growth objectives. Dormancy may be a strategic pause, but clarity on future direction is critical.
Compliance Maintenance: Continue timely filing of dormant accounts and confirmation statements to avoid penalties and maintain good standing with Companies House.
Consider Financial Planning: Engage with financial advisors to prepare for eventual trading, including budgeting for cash flow management, taxation, and potential funding rounds.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.